A nursing home pharmacy has agreed to settle at $9.25 million for claims that they received kickbacks for recommending drugs from a specific pharmaceutical company. The pharmaceutical company pleaded guilty to offering kickbacks and agreed to pay $1.5 billion for false advertisements that the drug was for dementia patients, when in reality it was for bipolar disorder and epilepsy.
“Elderly nursing home residents suffering from dementia have little control over the medications they receive and depend on the unbiased judgment of health-care professionals for their daily care,” said the attorney general on the case. “Kickbacks to entities making drug recommendations compromise their independence and undermine their role in protecting nursing home residents from the use of unnecessary drugs.”
